10-KPeriod: FY2011

IDEXX LABORATORIES INC /DE Annual Report, Year Ended Dec 31, 2011

Filed February 17, 2012For Securities:IDXX

Summary

IDEXX Laboratories, Inc. (IDXX) filed its 2011 10-K on February 16, 2012, providing a comprehensive overview of its business operations, financial condition, and strategic outlook. As a global leader in diagnostics and information technology for veterinarians, the company's performance is closely tied to the health of the companion animal market and the veterinary industry's adoption of advanced diagnostic tools. Investors should pay close attention to the company's revenue growth drivers, particularly within its key segments like Companion Animal Group and Water, where innovation and market penetration are crucial. The filing highlights the company's commitment to research and development, which fuels its product pipeline and competitive advantage. Management's Discussion and Analysis will likely offer insights into the company's financial performance, including revenue trends, profitability, and cash flow generation, alongside a discussion of the risks and uncertainties that could impact future results. Investors should review these sections carefully to understand the company's resilience and growth prospects in the dynamic animal health and laboratory diagnostics sectors.

Financial Highlights

52 data points
Beta

Revenue

$1.22B

53.0% Gross Margin

Net Income

$161.79M

13.3% Net Margin

EPS (Diluted)

$1.39

Total Assets

$1.03B

Cash & Equivalents

$183.90M

Free Cash Flow

$168.24M

Financial Statements
Beta
Revenue$1.22B
Cost of Revenue$572.18M
Gross Profit$646.51M
R&D Expenses$76.04M
Operating Income$236.22M
Interest Expense$3.55M
Net Income$161.79M
EPS (Basic)$1.43
EPS (Diluted)$1.39
Shares Outstanding (Basic)113.58M
Shares Outstanding (Diluted)116.43M

Key Highlights

  • 1The 10-K report for the fiscal year ending December 30, 2011, was filed by IDEXX Laboratories, Inc. on February 16, 2012.
  • 2The filing covers various aspects of the company's business, including its operations, financial health, risk factors, and corporate governance.
  • 3Key sections such as 'Management's Discussion and Analysis of Financial Condition and Results of Operations' and 'Financial Statements and Supplementary Data' are crucial for understanding the company's performance.
  • 4The report indicates that definitive proxy materials for the 2012 Annual Meeting, scheduled for May 9, 2012, will be incorporated by reference.
  • 5IDEXX Laboratories operates in the animal health sector, providing veterinary diagnostics and information technology.
  • 6Investors can find information on market performance, stockholder matters, and issuer purchases of equity securities in Item 5.

Frequently Asked Questions

IDEXX Laboratories, Inc. is a global leader in providing veterinary diagnostics, information technology, and services to the veterinary industry. Their offerings include diagnostic and information technology-based products and services primarily for the companion animal veterinary market.

This 10-K Annual Report covers the fiscal year ending on December 30, 2011.

Investors can find detailed information about the company's financial performance and condition in Part II, specifically under Item 7, 'Management's Discussion and Analysis of Financial Condition and Results of Operations,' and Item 8, 'Financial Statements and Supplementary Data.'

The key risks facing IDEXX Laboratories are detailed in Item 1A, 'Risk Factors.' While specific risks are not detailed in the provided excerpt, typical risks for such a company could include competition, regulatory changes, product development challenges, economic downturns affecting veterinary spending, and cybersecurity threats.